Plain-English translation of NCT06890169 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
OneSTOP is a new weight management program that uses telehealth (video visits with doctors and dieticians) combined with a smartphone app called EMPOWER to help people with obesity, type 2 diabetes, and fatty liver disease. The trial compares this new telehealth approach with traditional in-person doctor and dietician visits. Both groups receive personalized exercise plans, dietary guidance, and support to lose at least 5% of their body weight over 26 weeks.
Many people with obesity struggle to manage their weight while also dealing with related conditions like diabetes and fatty liver disease. This trial tests whether combining telehealth visits and a smartphone app might make weight management more accessible and effective than traditional in-person appointments alone.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the standard in-person program or the new OneSTOP telehealth program. Over 26 weeks, you will have about 8 visits total (with doctors and dieticians), with visits scheduled more frequently in the first 3 months. Depending on your group, you will either visit a clinic in person or use video visits and the EMPOWER app from home. You will receive a personalized exercise plan (aiming for 180 minutes of moderate activity per week), dietary guidance focused on reducing calories, and you will track your food and exercise in a diary for your healthcare team to review.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Singapore